Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citra Putra Realty Tbk. (CLAY) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Citra Putra Realty Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Citra Putra Realty Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Citra Putra Realty Tbk. trades at Rp2,780 (market cap 7.12T, 14.5K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Citra Putra Realty Tbk. is far larger — about 22.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (41.7K versus 14.5K). Which is the better fit depends on your goals.

CLAYDGNS
Market Cap
7.12T316.25B
Volume
14.5K41.7K
Lot
145417
Turnover
40.68M9.66M
Average Price
2,805.24231.65
Value
40.68M9.66M
Indicative Equilibrium Price
230
Indicative Equilibrium Volume
2.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CLAY
View details
DGNS
View details

About Citra Putra Realty Tbk.

PT Citra Putra Realty Tbk (“The Entity”) was established based on Notarial Deed of Herlina Pakpahan, S.H., No. 09 dated December 16, 2009. The majority shareholders (parent entity) of the Entity are PT Citra Putra Mandiri or better known as the OSO Group.

Read more on CLAY

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS